Clinical Trials Directory

Trials / Unknown

UnknownNCT02648399

Prospective Study on the Clinical Prognosis of Bilateral Central Lymph Node Dissection in the Patients With Unilateral Thyroid Papillary Carcinoma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
15 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study recruit the patients with unilateral papillary thyroid cancer before operation,the patients agree to enter the test,and divided into experimental and control group.experimental group patients receive the surgery including unilateral thyroid lobectomy and bilateral central lymph node dissection.and control group receive the surgery including unilateral thyroid lobectomy and unilateral central lymph node dissection.last the investigators compare numbers of patient with tumor recurrence and metastasis rate of 5 years,numbers of metastatic lymph node,and numbers of participants with adverse events related to treatment between two groups in order to evaluate the significance of bilateral lymph node dissection.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgery:BCND(bilateral central lymph node dissection)
PROCEDUREsurgery:UCND(unilateral central lymph node dissection)

Timeline

Start date
2015-12-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2016-01-07
Last updated
2016-01-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02648399. Inclusion in this directory is not an endorsement.